Parasite infectivity and immunity to Plasmodium falciparum gametocytes in Gambian children

Parasite Immunology

Volumn 26, Issue 4, 2004, Pages 159-165

  Drakeley, C J ^a,b,c,d   Eling, W ^c   Teelen, K ^c   Bousema, J T ^c   Sauerwein, R ^c   Greenwood, B M ^a,b   Targett, G A T ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Joint Malaria Programme   (Tanzania)

Author keywords

Gametes; Gametocytes; Malaria; P. Falciparum; Pfs230; Pfs48 45; Transmission blocking immunity

Indexed keywords

EPITOPE; IMMUNOGLOBULIN G1; PARASITE ANTIGEN;

AGE; AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GAMBIA; GAMETOCYTE; HOST PARASITE INTERACTION; HUMAN; MAJOR CLINICAL STUDY; NONHUMAN; PARASITE IMMUNITY; PARASITE TRANSMISSION; PARASITOSIS; PLASMODIUM FALCIPARUM; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; SEROLOGY;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, PROTOZOAN; ANTIGENS, PROTOZOAN; CARRIER STATE; CHILD, PRESCHOOL; CULICIDAE; HUMANS; INFANT; MALARIA, FALCIPARUM; MOLECULAR SEQUENCE DATA; PEPTIDES; PLASMODIUM FALCIPARUM;

PLASMODIUM FALCIPARUM; PROTOZOA;

EID: 4644224734     PISSN: 01419838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0141-9838.2004.00696.x     Document Type: Article

References (30)

1. Kaslow DC. Transmission-blocking vaccines, uses and current status of development. In. J Parasitol 1997; 27: 183-189.
2. Gwadz RW. Successful immunization against the sexual stages of Plasmodium gallinaceum. Science 1976; 17: 1150-1151.
3. Graves PM, Carter R, Quakyi IA, et al. Antibodies to Plasmodium falciparum gamete surface antigens in Papua New Guinea sera. Parasite Immunol, 1988; 10: 209-218.
4. Mendis KN, Munesinghe YD, de Silva YN, Keragalla I & Carter R. Malaria transmission-blocking immunity induced by natural infections of Plasmodium vivax in humans. Infection Immunity 1987; 55: 369-372.
5. Mulder B, Tchuinkam T, Dechering K, et al. Malaria transmission-blocking activity in experimental infections of An. gambiae with naturally infected Plasmodium falciparum gametocyte carriers. Trans Roy Soc Trop Med Hyg 1994; 88: 121-125.
6. Carter R, Graves PM, Quakyi IA & Good MF. Restricted or absent immune responses in human populations to Plasmodium falciparum gamete antigens that are targets of malaria transmission-blocking antibodies. J Exp Med 1989; 169: 135-147.
7. Ong CS, Zhang KY, Eida SJ, et al. The primary antibody response of malaria patients to Plasmodium falciparum sexual stage antigens which are potential transmission blocking vaccine candidates. Parasite Immunol 1990; 12: 447-456.
8. Roeffen W, Mulder B, Teelen K, et al. Association between anti-Pfs48/45 reactivity and Plasmodium falciparum transmission-blocking activity in sera from Cameroon. Parasite Immunol 1996; 18: 103-109.
9. Taylor R, Egan A, McGuinness D, et al. Selective recognition of malaria antigens by human serum antibodies is not genetically determined but demonstrates some features of clonal imprinting. Int Immunol 1996; 8: 905-915.
10. Healer J, McGuinness D, Carter R & Riley E. Transmission-blocking immunity to Plasmodium falciparum in malaria-immune individuals is associated with antibodies to the gamete surface protein Pfs230. Parasitology, 1999; 119: 425-433.
11. Premawansa S, Gamage-Mendis A, Perera L, et al. Plasmodium falciparum malaria transmission-blocking immunity under conditions of low endemicity as in Sri Lanka. Parasite Immunol 1994; 18: 35-42.
12. Drakeley CJ, Secka I, Correa S, Greenwood BM & Targett GAT. Host haematological parameters influencing the transmission of Plasmodium falciparum gametocytes to Anopheles gambiae s.l. mosquitoes. Trop Med Int Health 1999; 4: 131-138.
13. Nijhout M & Carter R. Gamete development in malaria parasites: bicarbonate-dependent stimulation by pH in vitro. Parasitology 1978; 76: 39-53.
14. Lensen A, van Druten J, Bolmer M, et al. Measurement by membrane feeding of reduction in Plasmodium falciparum transmission induced by endemic sera. Trans Roy Soc Trop Med Hyg 1996; 90: 20-22.
15. Ponnudurai T, Meuwissen JHETH, Leeuwenberg ADEM, Verhave J-P & Lensen AHW. The production of mature gametocytes of Plasmodium falciparum in continuous culture of different isolates infective to mosquitoes. Trans Roy Soc Trop Med Hyg 1992; 76: 242-250.
16. Vermeulen AN, Ponnudurai T, Beckers PJA, et al. Sequential expression of antigens on sexual stages of Plasmodium falciparum accessible to transmission-blocking antibodies in the mosquito. J Exp Med 1985; 162: 1460-1476.
17. Roeffen W, Beckers PJ, Teelen K, et al. Plasmodium falciparum: a comparison of the activity of Pfs230-specific antibodies in an assay of transmission-blocking immunity and specific competition ELISAs. Exp Parasitol 1995; 80: 15-26.
18. Billinsgley PF, Medley GF, Charlwood D & Sinden RE. Relationship between prevalence and intensity of Plasmodium falciparum infection in natural populations of Anopheles mosquitoes. Am J Trop Med Hyg 1994; 51: 260-270.
19. Drakeley CJ, Jawara M, Targett GAT, et al. Addition of artesunate to chloroquine for treatment of Plasmodium falciparum malaria in Gambian children causes a significant but short-lived reduction in infectiousness for mosquitoes. Trop Med Int Health 2004; 9: 53-61.
20. Riley EM, Bennet S, Jepson A, et al. (1994) Human antibody responses to Pfs 230, a sexual stage specific surface antigen of Plasmodium falciparum: non-responsiveness is a stable phenotype but does not appear to be genetically regulated. Parasite Immunol 1994; 16: 55-62.
21. Mendis KN & Carter R. Transmission blocking immunity may provide clues that antimalarial immunity is largely T-independent. Res Immunol 1991; 142: 687-690.
22. Healer J, McGuinness D, Hopcroft P, et al. Complement mediated lysis of Plasmodium falciparum gametes by malaria-immune human sera is associated with antibodies to the gamete surface antigen Pfs230. Infection Immunity 1999; 65: 3017-3023.
23. Read D, Lensen A, Bergarnie S, et al. Transmission-blocking antibodies against multiple, non-variant target epitopes of the Plasmodium falciparum gamete surface protein Pfs230 are all complement fixing. Parasite Immunol 1994; 16: 511-519.
24. Targett GAT, Harte PG, Eida S, Rogers NC & Ong CSL. Plasmodium falciparum sexual stage antigens: immunogenicity and cell mediated responses. Immunol Lett 1990; 25: 77-82.
25. Carter R, Coulson A, Bhatti S, et al. Predicted disulphide-bonded structures for three uniquely related proteins of Plasmodium falciparum, Pfs230, Pfs48/45 and Pf12. Mol Biochem Parasitol 1995; 71: 203-210.
26. Kocken CHM, Milek RLB, Lensen THW, et al. Minimal variation in the transmission-blocking vaccine candidate Pfs48/45 of the human malaria parasite Plasmodium falciparum. Mol Biochem Parasitol 1995; 69: 115-118.
27. Ranawaka MBR, Fleck SL, Alejo-Blanco AR & Sinden RE. Characterisation of the effector mechanisms of a transmission-blocking antibody upon differentiation of Plasmodium berghei gametocytes into ookinetes in vitro. Parasitology 1994; 109: 11-17.
28. Mulder B, Lensen T, Tchuinkam T, et al. Plasmodium falciparum: membrane feeding assays and competition ELISAs for the measurement of transmission reduction in sera from Cameroon. Exp Parasitol 1999; 92: 81-86.
29. Drakeley CJ, Mulder L, Tchuinkam T, et al. Transmission-blocking effects of sera from malaria exposed individuals on Plasmodium falciparum isolates from garnetocyte carriers. Parasitology 1998; 116: 417-423.
30. Graves PM, Doubrovsky A & Beckers P. Antibody responses to Plasmodium falciparum gametocyte antigens during and after malaria attacks in schoolchildren from Madang, Papua New Guinea. Parasite Immunol 1991; 13: 291-299.